However, trends towards different levels of MFN1 (higher) and PGC1α/β (lower) were observed in the poor outcome groups (G1 and G3) compared to the good outcome ones (G2 and G4), irrespective of AKI status. This evidence concerns the gene MFN1 and acute kidney injury.